Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase EARLY_PHASE1 1

Status

Unknown 4Recruiting 2Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1Lymphoid 1

Conditions

Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Histiocytosis, Sinus 1Hematologic Neoplasms 1Erdheim-Chester Disease 1

Interventions

Specimen Handling 334Magnetic Resonance Spectroscopy 334Radiotherapy 316Cyclophosphamide 296pembrolizumab 281Cisplatin 269Carboplatin 246Drug Therapy 238Blood Specimen Collection 233Biopsy 204Bevacizumab 185Gemcitabine 181venetoclax 172Radiosurgery 172Oxaliplatin 164Capecitabine 164fludarabine 161Paclitaxel 158Nivolumab 158Standard of Care 136Surveys and Questionnaires 131Surgical Procedures, Operative 130Dexamethasone 126Fluorouracil 124Docetaxel 113Rituximab 112tislelizumab 110Cytarabine 104Azacitidine 101Radiation 100

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × OTHER × 68Ga-pentixafor × Clear all
NCT05093335 2026-02-05

In-Human CXCR4 Imaging of Hematologic and Solid Tumors Using [68Ga]-Pentixafor-PET

Memorial Sloan Kettering Cancer Center

Phase EARLY_PHASE1 Recruiting
30 enrolled
LymphoidMyeloidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma, Histiocytosis, Sinus, Erdheim-Chester Disease

NCT05255926 2025-06-26

CXCR4-targeted PET/CT Imaging in Hematological Malignancies

Zhongnan Hospital

Phase NA Recruiting
300 enrolled
Other hematologic neoplasm

Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡